Vaccines Related News
Is it time TB vaccines were improved?
A new study commissioned by the World Health Organization (WHO) has predicted high health and economic returns from investment in new TB vaccines.
According to...
The uptake of MMR vaccines is lower in deprived neighbourhoods
Only 75% of children are receiving their first dose of MMR vaccines on time, according to a Queen Mary University study.
A 95% uptake of...
NHS offers second monkeypox vaccination for eligible people
The NHS will now offer a second monkeypox vaccination to everyone who is eligible in an effort to provide long-term protection against the virus.
Around...
40 million children are dangerously susceptible to the measles virus
New data from WHO and the CDC confirms that almost 40 million children worldwide are becoming dangerously susceptible to the measles virus.
The measles virus...
Defence’s successful study on the ACCUVAC-PT007 vaccine
Defence Therapeutics Inc. has announced its successful study on its ACCUVAC-PT007 vaccine, which targets cervical cancer.
Defence Therapeutics Inc. a Canadian biopharmaceutical company specialised in...
Increasing children’s vaccines with effective vaccine strategies
A new study has found that increasing children’s vaccines in sub-Saharan Africa could reduce the chance of fatal disease infection.
A research team from the...
Towards the next Council conclusions: are we doing enough for adult immunisation?
Ahead of a meeting between EU health ministers on vaccination policy in November this year, Mariano Votta and Daniela Quaggia from the Active Citizenship...
WHO: First data released on the global vaccine market since COVID
The World Health Organization (WHO) has captured the effects of COVID-19 on global vaccine markets in a new report.
WHO’s Global Vaccine Market Report...
COVID-19 vaccination does not affect nasopharyngeal cancer treatment
The COVID-19 vaccine has been proven not to reduce the efficacy of nasopharyngeal cancer treatment, despite previous concerns.
Drugs that activate the immune system against tumours...
Health Europa Quarterly Issue 23
Welcome to Health Europa Quarterly Issue 23, which features fascinating expert insights in the fields of infection control, future pandemic preparedness, antimicrobial resistance, women’s health,...
Defence Therapeutics applies Accum technology to anti-cancer vaccine
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is initiating a new research and...
Over 10 million people receive their COVID-19 booster
New data from NHS England has revealed that over 10 million people have received their COVID-19 booster.
The NHS has recently welcomed more people to...
Anxiety disorders had no effect on COVID-19 vaccine hesitancy
A new study has found that individuals with anxiety disorders were no less hesitant to get the COVID-19 vaccine.
Researchers from the University of Waterloo...
Ground-breaking Hepatitis C virus imaging could lead to vaccine
A team of researchers from Scripps Research and the University of Amsterdam have learned how to map high-resolution images of critical proteins on the...
Two-dose cholera vaccine strategy suspended by ICG
The International Coordinating Group (ICG), which manages emergency vaccine supplies has temporarily suspended their standard two-dose cholera vaccine strategy in response to the global...
New malaria vaccination could be deployed by 2023
A new malaria vaccination, developed by the University of Oxford, could be launched in 2023 after trials find it to be 80% effective.
The new...
Defence Therapeutics launches new AccuTOX lung cancer treatment
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the start...
Secop Group and B Medical Systems announce cold chain solution partnership
A new agreement between Secop Group and B Medical Systems will provide new cold chain solutions for the transportation of vaccines, biospecimens and temperature-sensitive...
The teenage meningitis vaccine delivers herd immunity to all ages
Researchers from the University of Oxford have found that the UK’s MenACWY meningitis vaccine programme generates herd protection protecting all age groups.
In the new...
New tool prioritises countries in need of COVID-19 vaccines
A new scoring tool developed by the University College London (UCL) assesses which countries require COVID-19 vaccines most.
Throughout the COVID-19 pandemic, vaccine inequalities were...